Title |
Myriad and its implications for patent protection of isolated natural products in the United States
|
---|---|
Published in |
Chinese Medicine, July 2014
|
DOI | 10.1186/1749-8546-9-17 |
Pubmed ID | |
Authors |
Alice Yuen-Ting Wong, Albert Wai-Kit Chan |
Abstract |
Extracts and compounds of natural products have potential as alternatives to current Western medicines. However, these products may not be patentable under the statutory requirements because of their naturally-occurring nature. This article analyzes the current patenting practices for natural products in the United States, particularly in light of the recent Supreme Court ruling in Myriad, and suggests an advantageous strategy for patenting these products. Briefly, isolated natural products per se are not patentable in the United States. Therefore, patenting focus should be placed on the modification, formulation, manufacture, and application of natural products. A detailed description of each invention is highly recommended for stronger support and broader coverage of the claims. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 1 | 8% |
Unknown | 12 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 3 | 23% |
Student > Master | 3 | 23% |
Professor > Associate Professor | 2 | 15% |
Student > Ph. D. Student | 2 | 15% |
Unspecified | 1 | 8% |
Other | 2 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 3 | 23% |
Social Sciences | 3 | 23% |
Business, Management and Accounting | 2 | 15% |
Unspecified | 1 | 8% |
Psychology | 1 | 8% |
Other | 3 | 23% |